The progression of patients with liver cancer from early to advanced stages varies from one year to six months, and is also specifically related to the biological behavior and pathological features of the tumor. The common pathological types of liver cancer are hepatocellular carcinoma and cholangiocellular carcinoma, or a mixture of both. Liver cancer occurs mainly due to a history of chronic viral hepatitis infection and alcoholic cirrhosis caused by long-term alcohol consumption. Patients with rapid progression, early to advanced stage within half a year, usually have low-differentiated liver cancer. For early-stage patients, surgical treatment can be actively chosen; while for advanced-stage patients, interventional embolization therapy and hepatic artery cannulation and perfusion chemotherapy can be chosen according to the needs of the condition. If the condition permits, systemic intravenous chemotherapy can also be chosen, and the purpose of these treatments is to control the development rate of tumor cells and improve the quality of life of patients in the late stage.